Q3 2024 · 13F-HR
BROADWOOD CAPITAL INCholdings as filed
Filed 2024-11-14 · accession 0000919574-24-006537
$1.30B
Reported value
7
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 61174X109 | MNST | MONSTER BEVERAGE CORP NEW | $432.8M | 33.2% | 8,295,690 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO | $400.0M | 30.7% | 10,768,431 | Common | SOLE |
| 05464C101 | AXON | AXON ENTERPRISE INC | $303.7M | 23.3% | 760,062 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $114.8M | 8.81% | 519,920 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $37.7M | 2.89% | 41,666,255 | Common | SOLE |
| 68235C206 | IMDX | ONCOCYTE CORP | $14.0M | 1.08% | 4,929,066 | Common | SOLE |
| 81751A108 | SER | SERINA THERAPEUTICS INC | $570,115 | 0.04% | 85,219 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.